ILCA STW25
Advancing HCC and BTC Treatment with Y90 & TACE
Session recordings now available!
As locoregional therapies took on new importance and treatment strategies became more complex, we asked: Why Y90? When should TACE be used? And how could we make the right choice for our patients?
The 2025 The 2025 ILCA Single Topic Workshop brought participants into the heart of a timely conversation—the evolving role of Y90 and TACE in treating HCC and BTCs—offering the opportunity to engage in close-knit discussions with some of the most respected experts in the field, in a setting designed for direct exchange, intimate conversations, and real collaboration.
Our heartfelt thank you goes to everyone who attended this special edition of the Single Topic Workshop, created in collaboration with Society of Interventional Oncology (SIO) to expand our community. Special thanks to our host AstraZeneca, our sponsors, speakers, and co-chairs who made the STW a memorable experience. While we are working on the 2026 edition, relive the moment with event photos and stay tuned for updates on #STW26.
Riad Salem and Edward Kim on collaboration between ILCA #STW25 and SIO NEXT Summit
Session recordings now available!
Rewatch the #STW25 sessions and catch-up on what you missed
Revisit the multidisciplinary sessions and expert presentations from our recent event. This is your opportunity to deepen your understanding of the latest advancements in liver cancer treatments and research—whenever it suits you.
At ILCA, we believe in keeping our community informed and empowered. That’s why we’re offering these session recordings free of charge to all ILCA members.
Not a member yet? No problem. You can still access the recordings at half the price of the event, or consider joining the ILCA Community to enjoy full benefits.
This year we focused on: